News
The acquisition will help Datavant transition its manual health records request process to digital.
The Microdose GLP-1Rx Program will offer low-dose GLP-1 prescriptions combined with behavioral coaching, clinical monitoring and medication management.
The new law bans the use of AI for mental health and therapeutic decision-making, but states it can be used for administrative and supplementary support services.
The company intends to partner with healthcare, biopharmaceutical, medical device and diagnostic companies.
The company began trading on the NYSE in May and saw an increase in its stock price upon the news of its second-quarter earnings.
The company aims to help providers secure stable pricing and access products and services for patients seeking reproductive and sexual healthcare.
The company will use the funds to scale its reach within the U.S. and to expand access to its offerings globally.
The California class action suit alleged that the Facebook parent company had collected data from the Flo Health period tracking app and used it without consent for targeted advertising.
The acquisition comes just months after Cerebral reached a settlement with the FTC over allegations of deceptive subscription and data-sharing practices.
The expanded guidelines lay out strategies for presenting medication information in a standardized way across electronic health records and e-prescribing platforms.